ZBIO (Zenas BioPharma) Change In Inventory: $0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZBIO Zenas BioPharma Inc ZBIO
8 GF Score
Price $31.33
! 3 Warning Signs
View Full Analysis

What is Zenas BioPharma Change In Inventory?

Zenas BioPharma ZBIO +0.58% 8 Change In Inventory is $0.00 Mil as of Jun. 2026. GuruFocus rates ZBIO with a GF Score™ of 8/100. The stock has 3 warning signs investors should review.

Zenas BioPharma's change in inventory for the quarter that ended in Jun. 2026 was $0.00 Mil. It means Zenas BioPharma's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Zenas BioPharma's change in inventory for the fiscal year that ended in Dec. 2025 was $0.00 Mil. It means Zenas BioPharma's inventory stayed the same from Dec. 2024 to Dec. 2025 .

Zenas BioPharma's Total Inventories for the quarter that ended in Jun. 2026 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Zenas BioPharma's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.00.

Zenas BioPharma  (NAS:ZBIO) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Zenas BioPharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0/0*365 / 4
=N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Zenas BioPharma's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0 / 0
=N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Zenas BioPharma's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0 / 1
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenas BioPharma Change In Inventory Related Terms

Zenas BioPharma Change In Inventory Historical Data

* Premium members only.

The historical data trend for Zenas BioPharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenas BioPharma Change In Inventory Chart

Zenas BioPharma Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Change In Inventory
0.00 0.00 0.00 0.00

Zenas BioPharma Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ZBIO
8GF Score
Zenas BioPharma Inc ZBIO
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenas BioPharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $0.00 Mil mean?
Zenas BioPharma (ZBIO) has a Change In Inventory of $0.00 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Zenas BioPharma and its competitors.
Is Zenas BioPharma's Change In Inventory too high?
Zenas BioPharma's current Change In Inventory is $0.00 Mil. Overall, Zenas BioPharma has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Zenas BioPharma's Change In Inventory compare to STOK and ZYME?
Zenas BioPharma's Change In Inventory of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Zenas BioPharma and its competitors. Zenas BioPharma's current Change In Inventory is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenas BioPharma stock overvalued right now?
Zenas BioPharma (ZBIO) has a current Change In Inventory of $0.00 Mil. The current Change In Inventory is $0.00 Mil. Zenas BioPharma's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Zenas BioPharma (ZBIO), the current Change In Inventory is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zenas BioPharma Business Description

Address 852 Winter Street, Suite 250, Waltham, MA, USA, 02451
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
8GF Score

Get the complete analysis for ZBIO

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.33
Price